Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study.
BioDrugs
; 34(1): 99-110, 2020 Feb.
Article
in En
| MEDLINE
| ID: mdl-31749113
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Renal Insufficiency, Chronic
/
Biosimilar Pharmaceuticals
/
Epoetin Alfa
/
Darbepoetin alfa
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BioDrugs
Journal subject:
ALERGIA E IMUNOLOGIA
/
GENETICA MEDICA
/
TERAPEUTICA
/
TERAPIA POR MEDICAMENTOS
Year:
2020
Document type:
Article
Country of publication:
Nueva Zelanda